RxDoctor Payments Data

Joseph Giovinco, DPM

Foot & Ankle Surgery · Peachtree City, GANPI 1316941115

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $16,326 of the $18,038 with a category attached, or 90.5%. 21 manufacturers reported payments, led by Fuse Medical, Inc. at 55.6% of the total. Reporting peaked in 2019 at $6,433 and has fallen 95.8% since, to $271 in 2025. Among foot & ankle surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,038in general payments, 2019–2025

Across 56 payments — averaging $322.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fuse Medical, Inc.$10K
  • Medtronic$6K
  • Amgen$271
  • Curonix LLC$211
  • Aroa Biosurgery Incorporated$173
  • Nevro Corp.$167
  • plus $711 from 15 others

What the payments were for

  • Royalty or licence$16,32691%
  • Travel & lodging$380%
  • Food & beverage$1,6629%
  • Education$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,038 in reported general payments places this provider in the 90th percentile of 239 foot & ankle surgery providers in Georgia.

See all foot & ankle surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$146,375
Medicare patients
327
Services billed
2,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium35$823
Colchicine23$602
Terbinafine Hcl32$371
Ketoconazole23$333
Cephalexin44$243
Clindamycin Hcl23$229
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$161
Ibuprofen19$61

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Peachtree City

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →